もみ合い。本日は東京メトロ＜9023＞が東証プライム市場に新規上場したことから投資資金が同社株に流入し、前日の新規公開（IPO）銘柄であるSchoo株は不安定な値動きになっている。東京メトロは公開価格（1200円）を35.8％上回る1630円で初値を記録した後も値を上げ、一時1768円を付けた。オルツ＜260A＞や伸和ホールディングス＜7118＞などの直近IPO銘柄も軟調に推移しており、投資家の関心は東京メトロに集中しているようだ。Rakulia Pharmaceuticals, stock code 4579, closed at 465, down 10.
Continuing decline. Rakulia Pharmaceuticals, through its Korean company HK InoEn, announced that Luoxin in China, a sublicensee, has obtained marketing approval from the National Medical Products Administration for a combination therapy for Helicobacter pylori infection using the acid secretion inhibitor 'tegoprazan' licensed by Rakulia Pharmaceuticals. Rakulia Pharmaceuticals will not receive any one-time payment for this matter, but it is expected that the approval in China will contribute to the improvement of business revenue and corporate value in the medium to long term.
Schoo, stock code 264A, closed at 708, down 11.
Stalemate. Today, due to the Tokyo Metro <9023> listing on the Tokyo Stock Exchange main board, investment funds have flowed into the company's stock, causing the previously listed (IPO) stock Schoo to experience unstable price movements. Tokyo Metro surpassed the public offering price (1200 yen) by 35.8% to reach 1630 yen at the opening bell, and continued to rise, reaching a peak of 1768 yen at one point. Recent IPO stocks such as Orts <260A> and Shinwa Holdings <7118> are also performing weakly, indicating that investor interest seems to be focused on Tokyo Metro.
Orts, stock code 260A, closed at 600, down 88.
Marked decline. Pushed by profit-taking sell due to the sharp rise the previous day. On the 21st, it was announced that the Ministry of Economy, Trade and Industry and the New Energy and Industrial Technology Development Organization (NEDO) have been selected for the second phase of the domestic AI development project "GENIAC", leading to a surge in buying the following day. On the 23rd, buying predominated again, briefly rising to 722 yen, but with the high of 765 yen since listing in sight, there is a high price caution and a shift to selling.
Base Food, stock code 2936, closed at 355, up 14.
Mark Kanayuki, the president of Melco Holdings <6676>, significantly increased his shareholding in Base Food by 14.03% (7.56 million 2500 shares, with the previous ownership ratio at 12.23%), as revealed in the amended report. The obligation to report arose on the 22nd, with the purpose of ownership stated as "long-term stable holding as a major shareholder." Mr. Maki has been acquiring Base Food shares in the market on the 16th, 18th, 21st, and 22nd of this month, which seems to have stimulated buying interest among other investors.
THECOO's stock price closed at 551, down by 5 points from 4255.
After hitting the daily limit up and setting a new year-to-date high, the stock rapidly lost its value. The announcement of a new shareholder benefit program continued to be seen as a buying incentive. At the end of December, THECOO will give 100 points (equivalent to 3,200 yen) to shareholders for use in their own funko community service, "Fanicon," and the OEM-provided services. THECOO's stock had surged the previous day as well, creating a situation where buying was driving more buying, but profit-taking sales pushed it down.
Yumetenbo's stock closed at 197, up by 50 points.
It hit the daily limit up. Out of the 11th new subscription rights, 4,720 units (40.9% of the total issuance) have been exercised, resulting in the issuance of 1,472,000 shares. Concerns about dilution of future share value have eased due to the large exercise, and the continuing favorable view appears to stem from the disclosure on the 21st that they have partnered with the online shopping mall "Temu," which operates in over 70 countries and has over 0.4 billion users.
